Sathish Sivaprakasam

Author

Texas Tech University Health Sciences Center ORCID

Also Known As

S Sivaprakasam, Sathish Sivaprakasam, Sivaprakasam Sathish

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Texas Tech University Health Sciences Center Texas Tech University Augusta University Georgia Regents Medical Center Max Planck Institute for Heart and Lung Research

About

Sathish Sivaprakasam is an author at Texas Tech University Health Sciences Center specializing in medicine, biochemistry, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	2.6K
2	Biochemistry	4	4	171
3	Cell Biology	3	3	284
4	Health Sciences	2	2	194
5	Natural Sciences	2	2	91

Sathish Sivaprakasam

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis Nagendra Singh, Ashish Gurav, Sathish Sivaprakasam, Immunity InflammationSuppresses Colonic InflammationMedicineCommensal Metabolite ButyrateImmunology	2014	2.2K
The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment Timothy Brown, Pushpak Bhattacharjee, Sabarish Ramachandran, Oncogene	2020	284
RCAD/Ufl1, a Ufm1 E3 ligase, is essential for hematopoietic stem cell function and murine hematopoiesis Mingming Zhang, Xinyuan Zhu, Yang Zhang, Cell Death and Differentiation Developmental BiologyUfm1 E3 LigaseMurine HematopoiesisMedicineStem Cell Mobilization	2015	172
Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions Ashish Gurav, Sathish Sivaprakasam, Yangzom D. Bhutia, Biochemical Journal	2015	148
An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis Sathish Sivaprakasam, Ashish Gurav, Amy V. Paschall, Oncogenesis	2016	130
Ufbp1 promotes plasma cell development and ER expansion by modulating distinct branches of UPR Huabin Zhu, Brinda Bhatt, Sathish Sivaprakasam, Nature Communications	2019	111
Dual targeting of<scp>l</scp>-carnitine-conjugated nanoparticles to OCTN2 and ATB<sup>0,+</sup>to deliver chemotherapeutic agents for colon cancer therapy Longfa Kou, Qing Yao, Sathish Sivaprakasam, Drug Delivery	2017	85
Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation Brinda Bhatt, Peng Zeng, Huabin Zhu, The Journal of Immunology	2018	69
Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth Marilyn Mathew, Nhi Thi Hong Nguyen, Yangzom D. Bhutia, Cancers GlycobiologyMetabolic SignatureMetabolic RemodelingWarburg EffectCancer Biology	2024	57
SLC6A14, a Na+/Cl−-coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling Mohd Omar Faruk Sikder, Sathish Sivaprakasam, Timothy Brown, Biochemical Journal Cancer BiologyAmino Acid DeprivationTumor BiologySignaling PathwayCancer Cell Biology	2020	55

Page 1